These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34480795)

  • 21. Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships.
    Chou WH; Yan FX; Robbins-Weilert DK; Ryder TB; Liu WW; Perbost C; Fairchild M; de Leon J; Koch WH; Wedlund PJ
    Clin Chem; 2003 Apr; 49(4):542-51. PubMed ID: 12651805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
    Céspedes-Garro C; Jiménez-Arce G; Naranjo ME; Barrantes R; Llerena A;
    Rev Biol Trop; 2014 Dec; 62(4):1659-71. PubMed ID: 25720195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Miotic action of tramadol is determined by CYP2D6 genotype.
    Slanar O; Nobilis M; Kvetina J; Mikoviny R; Zima T; Idle JR; Perlík F
    Physiol Res; 2007; 56(1):129-136. PubMed ID: 16497087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns.
    Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
    Am J Forensic Med Pathol; 2019 Mar; 40(1):8-18. PubMed ID: 30507617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study.
    Pedersen RS; Damkier P; Brosen K
    Clin Pharmacol Ther; 2005 Jun; 77(6):458-67. PubMed ID: 15961977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status.
    Barclay ML; Sawyers SM; Begg EJ; Zhang M; Roberts RL; Kennedy MA; Elliott JM
    Pharmacogenetics; 2003 Oct; 13(10):627-32. PubMed ID: 14515061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxycodone findings and CYP2D6 function in postmortem cases.
    Jakobsson G; Larsson R; Pellè L; Kronstrand R; Gréen H
    Forensic Sci Int Genet; 2021 Jul; 53():102510. PubMed ID: 33799050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of tramadol pharmacokinetics in correlation with CYP2D6 and clinical symptoms.
    Ahmadimanesh M; Naeini MB; Rouini MR; Shadnia S; Ghazi-Khansari M
    Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32681776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype and genotype analysis of debrisoquine hydroxylase (CYP2D6) in a black Zimbabwean population. Reduced enzyme activity and evaluation of metabolic correlation of CYP2D6 probe drugs.
    Masimirembwa C; Hasler J; Bertilssons L; Johansson I; Ekberg O; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 1996; 51(2):117-22. PubMed ID: 8911874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
    Borlak J; Hermann R; Erb K; Thum T
    Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.
    Lind AB; Reis M; Bengtsson F; Jonzier-Perey M; Powell Golay K; Ahlner J; Baumann P; Dahl ML
    Clin Pharmacokinet; 2009; 48(1):63-70. PubMed ID: 19071885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.
    Abdel-Rahman SM; Leeder JS; Wilson JT; Gaedigk A; Gotschall RR; Medve R; Liao S; Spielberg SP; Kearns GL
    J Clin Pharmacol; 2002 Jan; 42(1):24-9. PubMed ID: 11808821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).
    Matic M; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GAPJM; Weide JV; Wilffert B; Swen JJ; Guchelaar HJ; Deneer VHM; van Schaik RHN
    Eur J Hum Genet; 2022 Oct; 30(10):1105-1113. PubMed ID: 34267337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
    Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.
    Seripa D; Latina P; Fontana A; Gravina C; Lattanzi M; Savino M; Gallo AP; Melchionda G; Santini SA; Margaglione M; Copetti M; di Mauro L; Panza F; Greco A; Pilotto A
    Pain Med; 2015 Oct; 16(10):2012-23. PubMed ID: 25989235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.
    Elkalioubie A; Allorge D; Robriquet L; Wiart JF; Garat A; Broly F; Fourrier F
    Eur J Clin Pharmacol; 2011 Aug; 67(8):855-8. PubMed ID: 21691803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population.
    Halling J; Weihe P; Brosen K
    Br J Clin Pharmacol; 2008 Jan; 65(1):134-8. PubMed ID: 17764479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study.
    Tamminga WJ; Wemer J; Oosterhuis B; de Boer A; Vranckx S; Drenth BF; de Zeeuw RA; de Leij LF; Jonkman JH
    Eur J Clin Pharmacol; 2003 May; 59(1):57-64. PubMed ID: 12743673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.